CANNABICS PHARMACEUTICALS Buy Hold or Sell Recommendation

CNBX -- USA Stock  

Earnings Call  This Week

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding CANNABICS PHARMACEUTICALS INC is 'Strong Sell'. Macroaxis provides CANNABICS PHARMACEUTICALS buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CNBX positions. The advice algorithm takes into account all of CANNABICS PHARMACEUTICALS available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CNBX buy-and-hold prospective. Check also CANNABICS PHARMACEUTICALS Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon CANNABICS PHARMACEUTICALS INC has a mean deviation of 7.02, semi deviation of 0.0, standard deviation of 9.44, variance of 89.17, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on CANNABICS PHARMACEUTICALS. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available right now. To make sure CANNABICS PHARMACEUTICALS is not overpriced, please confirm all CANNABICS PHARMACEUTICALS fundamentals including its Price to Book, Cash and Equivalents as well as the relationship between Cash and Equivalents and Earnings Per Share . As CANNABICS PHARMACEUTICALS appears to be a penny stock we also recommend to validate its Net Income numbers.

CANNABICS PHARMACEUTICALS Trading Alerts and Improvement Suggestions

CANNABICS PHARMACEUTICALS generates negative expected return over the last 30 days
CANNABICS PHARMACEUTICALS has high historical volatility and very poor performance
CANNABICS PHARMACEUTICALS has some characteristics of a very speculative penny stock
CANNABICS PHARMACEUTICALS has high likelihood to experience some financial distress in the next 2 years
CANNIBICS PHARMAC currently holds about 3.52 M in cash with (3.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Latest headline from 1 Significant Development That Could Make GW Pharmaceuticals an Even Hotter Buy - Motley Fool

CANNABICS PHARMACEUTICALS Returns Distribution Density

Mean Return0.46Value At Risk16.13
Potential Upside15.37Standard Deviation9.44
 Return Density 


Alpha over DOW
Beta against DOW=0.06
Overall volatility
Information ratio =0.06


CANNABICS PHARMACEUTICALS INC is displaying above average volatility of 9.44 over selected time horizon. Investors should scrutinize CANNABICS PHARMACEUTICALS INC independently to make sure intended market timing strategies are aligned with expectations about CANNABICS PHARMACEUTICALS volatility. CANNABICS PHARMACEUTICALS INC is a potential penny stock. Although CANNABICS PHARMACEUTICALS may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in CANNABICS PHARMACEUTICALS INC. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare CANNABICS PHARMACEUTICALS to competition


Return On Equity13.03 (0.31) 
Return On Asset(22.48) (0.14) 
Current Valuation16.13 M16.62 B
Shares Outstanding134.46 M571.82 M
Price to Earning16.23 28.72 
Price to Book1.33 9.51 
Revenue9.84 K9.43 B
Gross Profit9.84 K27.38 B
EBITDA(3.11 M)3.9 B
Net Income1.13 M570.98 M
Cash and Equivalents3.52 M2.7 B
Cash per Share0.03 5.01 
Current Ratio9.81 2.16 
Book Value Per Share0.11 1.93 K
Cash Flow from Operations(3.09 M)971.22 M
Earnings Per Share0.009 3.12 
Number of Employees1118.84 K
Market Capitalization19.64 M19.03 B